Shanghai Novamab Biopharmaceuticals Co., Ltd.

This study tests a new inhaled drug called LQ036 in about 216 people aged 12 to 75 whose asthma is not well controlled despite using standard inhalers. The goal is to see if LQ036 improves lung function and reduces asthma attacks over 24 weeks. Participants will inhale the drug o…